Project Profiles
The most effective way for us to show you how we can help is by looking at our process.
Case Study: Handling Negative Publicity
Introduction
A leading global pharmaceutical company’s reputation was hurt following significant negative publicity over its handling of a high-profile partnership with a biotechnology company. An opinion survey of biotechnology management ranked them low in terms of ideal partners. At the same time, partnering with the most promising biotechs was more competitive then ever, and critical to the company’s future.
Read More…Case Study: The Anatomy of (Announcing) a Deal
Introduction
A small, ex-U.S. biotechnology company, focused on developing an orphan product for a very small disease population, was preparing to license their product to one of the largest pharmaceutical companies in the world. This created a significant communications challenge for the biotech, whose investors expected a complete acquisition, or a deal with a company experienced in orphan diseases.
Read More…Case Study: Advocacy Relations
Introduction
A biopharma company with an FDA-approved therapy was seeking a new product indication (Hepatitis C). The company was lesser-known and private, in contrast to its much larger, public competitors. The problem was threefold:
Read More…Case Study: Medical Meeting Publicity
Introduction
A biotechnology company with a late-stage brain tumor vaccine was preparing to unveil positive pivotal clinical data at a major cancer medical meeting, the American Society of Clinical Oncology (ASCO). Because the drug was partnered with a large pharmaceutical partner merely days before the presentation, an inclusive and transparent approach was imperative in order to achieve partner buy-in and ultimately ensure success.
Read More…